person
as of 2026-07-01Benedicto Crespo-Facorro, Professor
ORCID 0000-0003-0033-7132
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 12
3 publications · 2 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
University Hospital Marqués de Valdecilla, IDIVAL, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain. CIBERSAM Centro Investigación Biomédica en Red Salud Mental, Madrid, Spain
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
12
Publications
3 (2 high-value)
Trial investigator
yes
Trials led
13
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
NCT02305823Phase 4Completed
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
NCT03883204Phase 4Unknown
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
NCT02532491Phase 4Unknown
Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP
NCT02200588—Unknown
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
NCT02526030Phase 4Completed
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
NCT02897167—Completed
Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental Disorders
NCT02858102—Unknown
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NCT02220504—Completed
Cost-effectiveness of Interventions in First-episode Psychosis
NCT02916303—Unknown
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
NCT03090503Phase 4Unknown
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NCT03090490—Unknown
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
NCT02534363Phase 4Completed
Publications & congress
3
Convergent blood-brain barrier breakdown in schizophrenia and autism spectrum disorders: a systematic review of preclinical animal models.
Fluids and barriers of the CNS · 2026 · high-value
Mitochondrial signals in the bloodstream: Peripheral signature of mitochondrial dysfunction in mental health. A systematic review.
Neuroscience and biobehavioral reviews · 2026 · high-value
Decoding neurodevelopmental changes in schizophrenia: a comprehensive systematic review of neurogenic alterations.
Schizophrenia (Heidelberg, Germany) · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR